Diabetes care

• 

  Año 2012, Vol. 35, Número 11

  • Credit: Paginación R3

    • Texto completo

    pág. 3

    

  • Table of contents: Paginación R4-R6

    págs. 4-6

    

  • Table of contents: Paginación R4-R6

    • Texto completo

    págs. 4-6

    

  • Closed-Loop Systems: Diversity and Natural Selection

    Stuart A. Weinzimer

    • Resumen

    págs. 2111-2112

    

  • Superficial Wound Swabbing: A novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations

    Michael Schmoh, Stefan Beckert, Thomas O. Joos, Alfred Konigsrainer, Nicole Schneiderhan-Marra, Markus W. Löffler

    • Resumen

    págs. 2113-2120

    

  • Curcumin Extract for Prevention of Type 2 Diabetes

    Somlak Chuengsamarn, Suthee Rattanamongkolgul, Rataya Luechapudiporn, Chada Phisalaphong, Siwanon Jirawatnotai

    • Resumen

    págs. 2121-2127

    

  • Vista Monitoring of Individual Needs in Diabetes (MIND)-2: Follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study

    Frank J. Snoek, Nancy Y.A. Kersch, Ebbe Eldrup, Ilana Harman-Boehm, Norbert Hermanns, Andrzej Kokoszka, David R Matthews, Brian E. Mcguire, Mirjana Pibernik-Okanovic, Joelle Singer, Maartje De Wit, Soren E. Skovlund

    • Resumen

    págs. 2128-2132

    

  • Efficacy of Metabolic and Psychological Screening for Mood Disorders Among Children With Type 1 Diabetes

    Gnieszka Butwicka, Wojciech Fendler, Adam Zalepa, Agnieszka Szadkowska, Beata Mianowska, Agnieszka Gmitrowicz, Wojciech Mtynarskl

    • Resumen

    págs. 2133-2139

    

  • To compare the diagnostic accuracy and time expenditure of screening models based on glycated hemoglobin (HbA^sub 1c^) level and psychometric measures for mood disorder (MD) among children with type 1 diabetes. With semistructured clinical interviews (Schedule for Affective Disorders and Schizophrenia for Children-Present and Lifetime version, 120 min/patient) as a reference for diagnosing MD, including major depressive disorder (MDD), we tested 163 subjects, aged 8 to 18 years, with type 1 diabetes. We evaluated four screening approaches: 1) Children's Depression Inventory (CDI) at 30 min/pat

    R.M. Bergenstal, J. Rosenstock, Richard Arakaki, Melvin J. Prince, Yongming Qu, Vlkram P. Slnha, Daniel C. Howey, Scott J. Jacober

    • Resumen

    págs. 2140-2147

    

  • Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas

    Steven J. Russell, Firas H. El-Khatib, David M. Nathan, Rendra L. Magyar, John Jiang, Edward R. Damiano

    • Resumen

    págs. 2148-2155

    

  • Intervention Costs and Cost-Effectiveness of a Successful Telephonic Intervention to Promote Diabetes Control

    Clyde B. Schechter, Hillel W. Cohen, Celia Shmukler, Elizabeth A. Walker

    • Resumen

    págs. 2156-2160

    

  • Psychometric Evaluation of the Adherence in Diabetes Questionnaire

    Lene J. Kristensen, Mlkael Thastum, Anne H. Mose, Niels H. Birkebaek

    • Resumen

    págs. 2161-2166

    

  • White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study

    Tandy Aye, Naama Barnea-Goraly, Christian Ambler, Sherry Hoang, Kristin Schleifer, Yaena Park, Jessica Drobny, Darrell M. Wilson, Allan L. Reiss, Bruce A. Buckingham

    • Resumen

    págs. 2167-2173

    

  • Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial

    Irl B. Hirsch, Bruce Bode, Jean-Pierre Courreges, Patrik Dykiel, Edward Franek, Kjeld Hermansen, Allen King, Henriette Mersebach, Melanie Davies

    • Resumen

    págs. 2174-2181

    

  • The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes

    Michael J. O'Grady, Adam Retterath, Barry Keenan D., Natalie Kurtz, Martin Cantwell, Glenn Spital, Michael N. Kremliovsky, Anirban Roy, Elizabeth A. Davis, Timothy W Jones, Trang T Ly

    • Resumen

    págs. 2182-2187

    

  • A Learner-Centered Diabetes Management Curriculum: Reducing resident errors on an inpatient diabetes pathway

    Daniel J. Desalvo, Larme W. Greenberg, Celia L. Henderson, Fran R. Cogen

    • Resumen

    págs. 2188-2193

    

  • Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention

    Young-Hoon Jeong, Udaya S. Tantry, Yongwhi Park, Tae Jung Kwon, Jeong Rang Park, Seok-Jae Hwang, Kevin P. Bliden, Eun-Ha Koh, Kwak Choong Hwan, Jin-Yong Hwang, Sunjoo Kim, Paul A. Gurbel

    • Resumen

    págs. 2194-2197

    

  • Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes

    Sunder Mudaliar, Debra A. Armstrong, Annie A. Mavian, Robin O'connor-Semmes, Patricia K. Mydlow, June Ye, Elizabeth K. Hussey, Derek J. Nunez, Robert R. Henry, Robert L. Dobbins

    • Resumen

    págs. 2198-2200

    

  • Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study

    Jamie Morton, Sophia Zoungas, Qiang Li, Anushka Patel, John Chalmers, Mark Woodward, David S. Celermajer, Joline W.J. Beulens, Ronald P. Stolk, Paul Glasziou, Martin K.C. Ng

    • Resumen

    págs. 2201-2206

    

  • Effect of Intensive Multifactorial Treatment Compared With Routine Care on Aortic Stiffness and Central Blood Pressure Among Individuals With Screen-Detected Type 2 Diabetes: The ADDITION-Denmark study

    Nanna B. Johansen, Morten Charles, Dorte Vlstisen, Signe S. Rasmussen, Niels Wiinberg, Johnsen Knut Borch, Torsten Lauritzen, Annelli Sandbaek, Daniel R Witte

    • Resumen

    págs. 2207-2214

    

  • Breast-Feeding and Childhood-Onset Type 1 Diabetes: A pooled analysis of individual participant data from 43 observational studies

    Chris Cardwell, Lars C. Stene, Johnny Ludvigsson, Joachim Rosenbauer, Ondrej Cinek, Jannet Svensson, Francisco Pérez Bravo, Anjum Memon, Suely G. Gimeno, Emma J.K. Wadsworth, Elsa S. Strotmeyer, Michael J. Goldacre, Katja Radon, Lee-Ming Chuang, Roger C. Parslow, Amanda Chetwynd, Kyriaki Karavanaki, Girts Brigis, Paolo Pozzilli, Brone Urbonaitê, Edith Schober, Gabriele Devoti, Sandra Sipetic, Geir Joner, Constantin Ionescu-Tirgoviste

    • Resumen

    págs. 2215-2225

    

  • Determinants of Racial/Ethnic Disparities in Incidence of Diabetes in Postmenopausal Women in the U.S.: The Women's Health Initiative 1993-2009

    Yunsheng Ma, James R. Hébert, Ann E. Man Son Jo, Raji Balasubramanian, Simin Liu, Michael J. LaMonte, Bird Chloe E., Judith K. Ockene, Yongxia Qiao, Barbara Olendzki, Kristin L. Schneider, Milagros C. Rosal, Deidre M. Sepavich, Jean Wactawski-Wende, Marcia L. Stefanick, Lawrence S. Phillips, Ira S. Ockene, Robert C. Kaplan, Gloria E. Sarto, Lorena García, Barbara V. Howard

    • Resumen

    págs. 2226-2234

    

  • Periodontal Infection, Systemic Inflammation, and Insulin Resistance: Results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004

    Ryan T. Demmer, Anthony Squillaro, Panos N. Papapanou, Michael Rosenbaum, William T. Friedewald, David R. Jacobs Jr., Moise Desvarieux

    • Resumen

    págs. 2235-2242

    

  • Adverse microbial exposures might contribute to diabetogenesis. We hypothesized that clinical periodontal disease (a manifestation of microbial exposures in dysbiotic biofilms) would be related to insulin resistance among diabetes-free participants. The roles of inflammatory mediation and effect modification were also studied. The continuous National Health and Nutrition Examination Survey 1999-2004 enrolled 3,616 participants (51% women) who received a periodontal examination and fasting blood draw. Participants were mean age (± SD) 43 ± 17 years and 28% Hispanic, 52% Caucasian, 17% African A

    Sarah Stark Casagrande, Catherine Cowie

    • Resumen

    págs. 2243-2249

    

  • Health Utility Scores for People With Type 2 Diabetes in U.S. Managed Care Health Plans: Results from Translating Research Into Action for Diabetes (TRIAD)

    Ping Zhang, Morton B Brown, Dori Bilik, Ronald T. Ackermann, Rui Li, William H. Herman

    • Resumen

    págs. 2250-2256

    

  • Vista Universal Drug Coverage and Socioeconomic Disparities in Major Diabetes Outcomes

    Gillian L. Booth, Phoebe Bishara, Lorraine Lipscombe, Baiju R. Shah, Denice S. Feig, Onil Bhattacharyya, Arlene S. Bierman

    • Resumen

    págs. 2257-2264

    

  • Alternative Markers of Hyperglycemia and Risk of Diabetes

    Stephen P. Juraschek, Michael W. Steffes, Edgar R. Miller, Elizabeth Selvin

    • Resumen

    págs. 2265-2270

    

  • Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes: The PPP-Botnia Study

    Antti-Jussi Pyykkönen, Bo Isomaa, Anu-Katriina Pesonen, Johan G. Eriksson, Leif Groop, Tllnamaija Tuomi, Katri Raikkonen

    • Resumen

    págs. 2271-2278

    

  • Estimation of Expected Life-Years Saved From Successful Prevention of End-Stage Renal Disease in Elderly Patients With Diabetes: A nationwide study from Taiwan

    Deng-Chi Yang, Lukas Jyuhn-Hsiarn Lee, Chih-Cheng Hsu, Yu-Yin Chang, Ming-Cheng Wang, Wei-Hung Lin, Chia Ming Chang, Jung-Der Wang J

    • Resumen

    págs. 2279-2285

    

  • Poverty Increases Type 2 Diabetes Incidence and Inequality of Care Despite Universal Health Coverage

    Chih-Cheng Hsu, Cheng-Hua Lee, Mark L. Wahlqvist, Hsiao-Ling Huang, Hsing-Yi Chang, Likwang Chen, Shu-Fang Shih, Shyi-Jang Shin, Wen-Chen Tsai, Ted Chen, Chi-Ting Huang, Jur-Shan Cheng

    • Resumen

    págs. 2286-2292